Pexxes GmbH

Hannover, DE · 1 known investors

Pexxes develops affordable biologic therapeutics for treating chronic diseases in dogs, cats, and horses. The company uses advanced antibody discovery technologies including phage display to create high-affinity binders for veterinary medicine applications.